The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Douville, R. N.
Right arrow Articles by HayGlass, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Douville, R. N.
Right arrow Articles by HayGlass, K. T.
The Journal of Immunology, 2006, 176: 5848-5855.
Copyright © 2006 by The American Association of Immunologists

Human Metapneumovirus Elicits Weak IFN-{gamma} Memory Responses Compared with Respiratory Syncytial Virus1

Renée N. Douville*, Nathalie Bastien§, Yan Li{dagger},§, Pierre Pochard*, F. Estelle R. Simons*,{ddagger} and Kent T. HayGlass2,*,{dagger},{ddagger}

* Department of Immunology, {dagger} Department of Medical Microbiology, and {ddagger} Department of Pediatrics/Child Health, University of Manitoba, and § Canadian Science Centre for Human and Animal Health, Winnipeg, Canada

Human metapneumovirus (MPV) is a recently discovered pathogen that causes repeated lower respiratory tract infections beginning in infancy. The prevalence, nature and control of human regulatory responses to MPV are unknown. In this study, we develop and optimize systems to evaluate MPV-driven cytokine responses. Using primary culture of human PBMC from previously exposed adults, MPV-stimulated responses were directly compared with those elicited by genetically and clinically similar respiratory syncytial virus (RSV). Intense IL-6 production was evident following culture with infectious or inactivated RSV. MPV elicited IL-6 responses averaging 3.5-fold more intense (p < 0.001). Virus-dependent expression of IL-11, IL-12, IFN-{alpha}, and other innate immunity cytokines differed little between MPV and RSV. When examining adaptive immunity, RSV infection elicited strong IFN-{gamma} responses by all 60 adults. In marked contrast, MPV elicited IFN-{gamma} in a lower frequency of adults (p < 0.002) and at levels averaging 6-fold weaker (p < 0.001). These Th1-dominated responses were CD4, CD8, CD86 dependent, and were closely paralleled by strong virus-driven IL-10 and CCL5 production. For MPV and RSV, Th2 (IL-5, IL-13) responses were sporadic, occurring in 10–40% of the population. Thus, MPV and RSV, although both ubiquitous and leading to very high levels of infection, seroconversion, and clinically similar presentation in the population, evoke distinct innate and adaptive T cell-dependent cytokine responses. Although both viruses yield Th1-dominated responses with strong IL-10 and CCL5 production, MPV restimulation results in markedly more robust IL-6 and significantly weaker adaptive cytokine responses, in both prevalence and intensity, than does RSV.




This article has been cited by other articles:


Home page
J. Virol.Home page
R. N. Douville, R.-C. Su, K. M. Coombs, F. E. R. Simons, and K. T. HayGlass
Reovirus Serotypes Elicit Distinctive Patterns of Recall Immunity in Humans
J. Virol., August 1, 2008; 82(15): 7515 - 7523.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M.-E. Hamelin, C. Couture, M. K. Sackett, and G. Boivin
Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus
J. Gen. Virol., December 1, 2007; 88(12): 3391 - 3400.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.